Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorUniversity of Tennessee

About this trial

The purpose of this study is to compare opioid prescribing practices by either routine provider prescribing practices, or with the use of a calculator, i.e., the Opioid Calculator, published by the University of Michigan (www.opioidcalculator.org), with the intent of decreasing the number of pills.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Women aged 18 to 80

Undergoing planned laparoscopic hysterectomy as a day surgery procedure

Disqualifiers

Women aged 18 to 80

Undergoing a non-laparoscopic unplanned surgical procedure

Patients with a history of opioid use disorder or current opioid use disorder

Trial design

Design model

Parallel

Treatments tested in this trial

  • 5x Oxycodone Oral Tablets

    Other intervention

    Participants will be prescribed 5 doses of 5mg tablets of oxycodone for postoperative pain relief.

  • 16x Oxycodone Oral Tablets

    Other intervention

    Participants will be prescribed 16 doses of 5mg tablets of oxycodone for postoperative pain relief.

Treatment groups

12 Participants
are divided into 2 treatment groups
Group A: 5 DosesExperimental treatment 1 intervention
Group B: 16 DosesActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of pills used

All participants will be contacted on postoperative days 2 and 7 to inquire how many pills they have taken

Time frame
Within 1 week following surgery

Secondary outcomes

1

Postoperative pain

All participants will be contacted on postoperative days 2 and 7, and at their two-week follow-up visit to inquire where their pain level is on the Visual Analog Scale (VAS). This scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating worst possible pain.

Time frame
Within 2 weeks following surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.